MedPath

IMMIX BIOPHARMA AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

IMX-110 in Patients With Advanced Solid Tumors

Phase 1
Active, not recruiting
Conditions
Solid Tumor, Adult
Advanced Solid Tumors
Breast Cancer
Ovarian Cancer
Pancreatic Cancer
Interventions
First Posted Date
2017-12-22
Last Posted Date
2023-09-28
Lead Sponsor
Immix Biopharma Australia Pty Ltd
Target Recruit Count
70
Registration Number
NCT03382340
Locations
🇺🇸

Sarcoma Oncology Research Center, Santa Monica, California, United States

🇦🇺

St George Hospital, Sydney, New South Wales, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.